Subscribe to RSS
DOI: 10.1055/s-0043-1760763
Extranodal Rosai-Dorfman Disease of Breast Mimicker of Breast Malignancy
Abstract
Rosai-Dorfman-Destombes (RDD) disease is also known as sinus histiocytosis with massive lymphadenopathy. It is an uncommon heterogeneous disease of children and young adults. Most of the patients with RDD generally present with painless lymphadenopathy, while extranodal and multisystem manifestation of the disease is unusual. The diagnosis is based on the imaging with clinicopathological correlation. Flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography is useful for the initial staging of the RDD lesions, which have similar appearance and avidity like intermediate and high-grade lymphomas. Here, we present the case of a 55-year-old female presented with left breast mass that turned out to be the extranodal Rosai-Dorfman disease.
Publication History
Article published online:
11 April 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bruce-Brand C, Schneider JW, Schubert P. Rosai–Dorfman disease: an overview. J Clin Pathol 2020; 73 (11) 697-705
- 2 Carbone A, Passannante A, Gloghini A, Devaney KO, Rinaldo A, Ferlito A. Review of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of head and neck. Ann Otol Rhinol Laryngol 1999; 108 (11 Pt 1): 1095-1104
- 3 Iancu G, Gica N, Mustata LM, Panaitescu AM, Vasile D, Peltecu G. Rosai-Dorfman disease: breast involvement-case report and literature review. Medicina (Kaunas) 2021; 57 (11) 1167
- 4 Vaidya T, Mahajan A, Rane S. Multimodality imaging manifestations of Rosai-Dorfman disease. Acta Radiol Open 2020; 9 (08) 2058460120946719
- 5 Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT follow-up of Rosai-Dorfman disease. Clin Nucl Med 2015; 40 (08) e420-e422
- 6 Goyal G, Ravindran A, Young JR. et al; Mayo Clinic Histiocytosis Working Group. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica 2020; 105 (02) 348-357
- 7 Deen IU, Chittal A, Badro N, Jones R, Haas C. Extranodal Rosai-Dorfman disease- a review of diagnostic testing and management. J Community Hosp Intern Med Perspect 2022; 12 (02) 18-22